Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
The Journal of Antimicrobial Chemotherapy|November 2, 2017
Genomic sequences of Streptococcus agalactiae with high-level gentamicin resistance, collected in the BSAC bacteraemia surveillanceMichel Doumith, Shazad Mushtaq, Veronique Martin, et al.
BMC Infectious Diseases|July 27, 2020
Modifiable healthcare factors affecting 28-day survival in bloodstream infection: a prospective cohort studyRebecca N Evans, Katie Pike, Chris A Rogers, et al.
Antimicrobial Agents and Chemotherapy|October 6, 2022
Exploring Cluster-Dependent Antibacterial Activities and Resistance Pathways of NOSO-502 and Colistin against Enterobacter cloacae Complex SpeciesLucile Pantel, François Guérin, Marine Serri, et al.
Thorax|July 4, 2024
Antibiotic pharmacokinetics in infected pleural effusionsDavid T Arnold, Liam Read, Oliver Waddington, et al.
The Journal of Antimicrobial Chemotherapy|February 12, 2005
Pharmacokinetic studies of linezolid and teicoplanin in the critically illTony Whitehouse, Jorge A Cepeda, Rob Shulman, et al.
BMC Genomics|September 6, 2017
Evolution of mobile genetic element composition in an epidemic methicillin-resistant Staphylococcus aureus: temporal changes correlated with frequent loss and gain eventsDorota Jamrozy, Francesc Coll, Alison E Mather, et al.
BMJ Open|July 31, 2016
Retrospective observational study to assess the clinical management and outcomes of hospitalised patients with complicated urinary tract infection in countries with high prevalence of multidrug resistant Gram-negative bacteria (RESCUING)Evelyn Shaw, Ibironke Addy, Margaret Stoddart, et al.
Emergency Medicine Journal : EMJ|May 22, 2021
Predicting outcomes of COVID-19 from admission biomarkers: a prospective UK cohort studyDavid T Arnold, Marie Attwood, Shaney Barratt, et al.
Jac-Antimicrobial Resistance|July 11, 2026
Defining a target product profile for antimicrobials to treat severe paediatric bacterial enteric infections in low- and medium-income countries, caused by <i>E. coli</i>, <i>Shigella</i>, <i>Salmonella</i> and <i>Campylobacter</i> speciesMarie Attwood, Tamara Choola, Erin Duffy, et al.
Eclinicalmedicine|January 9, 2023
Oral minocycline plus rifampicin versus oral linezolid for complicated skin and skin structure infections caused by methicillin-resistant <i>Staphylococcus aureus</i>: The AIDA open label, randomized, controlled Phase 4 trialAntigone Kotsaki, Nikolaos Tziolos, Theano Kontopoulou, et al.
Pageof 8